- Report
- February 2024
- 175 Pages
Global
From €4802EUR$5,000USD£4,134GBP
- Report
- March 2024
- 200 Pages
Global
From €3986EUR$4,150USD£3,432GBP
- Report
- April 2023
- 110 Pages
Global
From €4562EUR$4,750USD£3,928GBP
- Report
- March 2022
- 142 Pages
Global
From €7203EUR$7,500USD£6,202GBP
- Report
- November 2020
- 101 Pages
Global
€21130EUR$22,000USD£18,192GBP
- Report
- May 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,191GBP
- Report
- May 2024
- 50 Pages
Global
From €2545EUR$2,650USD£2,191GBP
Fenofibrate is a lipid-lowering medication used to treat high cholesterol and triglyceride levels in people with cardiovascular disease. It is a fibrate drug, which works by increasing the breakdown of triglycerides in the liver and reducing the production of very low-density lipoprotein (VLDL) cholesterol. Fenofibrate is also used to reduce the risk of stroke, heart attack, and other heart complications in people with high cholesterol and triglyceride levels.
Fenofibrate is available in both generic and brand-name formulations, and is sold in tablet, capsule, and liquid forms. It is typically taken once or twice daily, with or without food. Common side effects of fenofibrate include nausea, stomach pain, and diarrhea.
Some companies that produce fenofibrate include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more